Skip to main content
Equibles
BBNX logo

BBNX · Beta Bionics, Inc. · Metrics

Track BBNX — free

Use BBNX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BBNX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$16.57 -0.02 (-0.12%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$745.48M
Shares
44.99M

BBNX metrics

63 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$16.57
Market cap
$745.48M

Price action

20 metrics
Price change (1W)
-14.7%
Price change (30D)
-5.7%
Price change (3M)
+14.0%
Price change (6M)
+59.5%
Price change (YTD)
-45.6%
Price change (1Y)
-34.6%
Trailing year
Price change (5Y)
—
52-week high
$31.99
52-week low
$8.86
Change from 52-week high
-48.2%
Change from 52-week low
+87.0%
Annualized volatility
81.2%
Annualized volatility (3M)
71.6%
Beta
1.4
RSI (14D)
40.0
Price vs SMA 50
-3.9%
Price vs SMA 200
+0.3%
Avg volume (3M)
1.14M
Relative volume
0.6
Average dollar volume
$18.82M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
44.99M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
6.3×
reciprocal yield 16.0%
P / book
2.9
reciprocal yield 34.4%
FCF yield
-8.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-9.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
58.3%
Operating margin
-69.8%
Trailing 12 months
Net margin
-61.3%
Gross profit (TTM)
$69.40M
Operating profit (TTM)
−$83.02M
Net income (TTM)
−$72.97M
Trailing 12 months
Diluted EPS (TTM)
$-1.51
FCF margin
-51.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$6.48

Growth

11 metrics
Revenue growth YoY
+37.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$119.01M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-28.5%
Return on assets
-25.0%
Debt / equity
—
Current ratio
8.9
EBITDA (TTM)
—
Free cash flow (TTM)
−$61.41M
Quick ratio
8.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$180.49M
Latest balance sheet
Cash & equivalents
$44.32M
Total assets
$292.39M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$55.81M
Capital expenditures (TTM)
$5.60M
R&D (TTM)
$38.92M
SG&A (TTM)
—
Stock compensation (TTM)
$21.20M
R&D / revenue
32.7%
Stock compensation / revenue
17.8%

Ownership (13F)

3 metrics
13F filers
136
13F filer change QoQ
+4
Institutional ownership
106.9%

Short interest

3 metrics
Short interest
20.9%
Latest settlement · 9.0 days to cover
Days to cover
9.0d
Short-squeeze score
87 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.72M
Insider-sentiment score
21 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1674632 CUSIP 08659B102 13F (30d) 55 filings 55 filers Visit website Investor relations